SMS Pharmaceuticals

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue167.45162.97247.45165.82198.05
Expenses152.29146.56225.84144.04178.12
EBITDA28.6330.3735.1434.8333.17
EBIT20.7322.3627.2226.4524.55
Profit Before Tax15.1616.4121.6121.7919.94
Net Profit12.0512.1715.9216.3314.26
Financial Ratios
Operating Profit Margin17.18%18.81%14.29%21.18%16.86%
Net Profit Margin7.23%7.54%6.48%9.93%7.25%
Earning Per Share (Diluted)1.421.441.881.931.68
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ